Inhibitory effects of berberine on ATP-sensitive K+ channels in cardiac myocytes

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 307-315

  Wang, Yong Xiao ^a,b   Zheng, Yun Min ^a   Zhou, Xiao Bao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ATP sensitive; Berberine; Cardiac cell; K+ channel; Microelectrode recording; Patch clamp

Indexed keywords

BERBERINE; CROMAKALIM; GLIBENCLAMIDE; POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEART MUSCLE CELL; HYPOXIA; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; BERBERINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HEART; MALE; POTASSIUM CHANNELS;

EID: 0030571555     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00663-2     Document Type: Article

References (40)

1. Chi, L., A.C. Uprichard and B.R. Lucchesi, 1990, Profibrillary actions of pinacidil in a conscious canine model of sudden coronary death, J. Cardiovasc. Pharmacol. 5, 452.
2. + channel modification by metabolic inhibition in isolated guinea-pig ventricular myocytes, J. Physiol. 465, 163.
3. Edwards, G. and A.H. Weston, 1993, The pharmacology of ATP-sensitive potassium channels, Annu. Rev. Pharmacol. Toxicol. 33, 597.
4. Hamill, O.P., A. Marty, E. Neher, B. Sakmann and F.J. Sigworth, 1981, Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflüg. Arch. 391, 85.
5. Huang, W., 1990, Ventricular tachycardias treated with berberine, Chin. J. Cardiovasc. Dis. 18, 155.
6. + loss and arrhythmias in rat hearts: effect of glibenclamide, a sulfonylurea, Circ. Res. 66, 478.
7. max by lidocaine but not by disopyramide in guinea-pig papillary muscles, N.-S. Arch. Pharmacol. 337, 203.
8. Marin-Neto, J.A., B.C. Maciel, A.L. Seeches and L. Gallo Jr., 1988, Cardiovascular effects of berberine in patients with severe congestive heart failure, Clin. Cardiol. 11, 253.
9. Maroko, P.R. and W. Ruzyllo, 1983, Hemodynamic effects of berberine, a new inotropic drug, in patients with congestive heart failure, Circulation 68 (Suppl. 3), 374.
10. Mestre, M., D. Escande and I. Cavero, 1988, Glibenclamide blocks the transmembrane action potential shortening evoked by cromakalim in guinea-pig papillary muscle. Br. J. Pharmacol. 95, 571P.
11. + channel blockers on the action potential shortening in hypoxic and ischemic myocardium, Br. J. Pharmacol. 103, 1019.
12. Neto, F.R., 1993, Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit, Br. J. Pharmacol. 108, 534.
13. Nichols, C.G. and W.J. Eederer, 1991, Adenosine triphosphate-sensitive potassium channels in the cardiovascular system, Am. J. Physiol. 261, H1675.
14. + channels in cardiac muscle, Nature 305, 147.
15. Noma, A. and T. Shibasaki, 1985, Membrane current through adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells, J. Physiol. 363, 463.
16. Ribeiro, L.G.T., B.L. Bowker and P.R. Maroko, 1982, Beneficial effects of berberine on early mortality after experimental coronary artery occlusion in rats, Circulation 66 (Suppl. 2), 56.
17. Sabir, M., M.H. Akhter and N.K. Bhide, 1978, Further studies on pharmacology of berberine, Ind. J. Physiol. Pharmacol. 22, 9.
18. + current in cardiac muscle, Proc. Natl. Acad. Sci. USA 85, 8360.
19. Shaffer, J.E., 1985, Inotropic and chronotropic activity of berberine on isolated guinea pig atria, J. Cardiovasc. Pharmacol. 7, 307.
20. + channel by ER-001533, a newly synthesized vasorelaxant, Circ. Res. 70, 1054.
21. Smallwood, J.K. and M.I. Steinberg, 1988, Cardiac electrophysiological effects of pinacidil and related pyridylcyanoguanidines: relationship to antihypertensive activity, J. Cardiovasc. Pharmacol. 12, 102.
22. Sun, X.D., J.M. Li, L.J. Tian, Y.P. Wang. Y.F. Yu and K.Y. Zhang, 1989, Effect of berberine on slow inward ionic current in guinea pig ventricular papillary muscles, Acta Pharmacol. Sin. 10, 130.
23. Tweedie, D., G. Boachie-Anash, C.G. Henderson and K.A. Kane, 1993, Attenuation by phentolamine of hypoxia and levcromakalim-induced abbreviation of the cardiac action potential, Br. J. Pharmacol. 110, 1222.
24. Trube, G. and J. Hescheler, 1983, Potassium channels in isolated patches of cardiac cell membrane, N.-S. Arch. Pharmacol. 322, R64.
25. Trube, G. and J. Hescheler, 1984, Inward-rectifying channels in isolated patches of the heart cell membrane: ATP dependence and comparison with cell-attached patches, Pflügers Arch. 401, 178.
26. + channel in ventricular cell of guinea-pig, J. Physiol. 437, 239.
27. Vik-Mo, H., D.B. Faria, W.M. Cheung and P.R. Maroko, 1983, Beneficial effects of berberine on left ventricular function in dogs with heart failure, Clin. Res. 31, 224A.
28. Wang, Y.X. and M. Korth, 1995, Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium, Circ. Res. 76, 645.
29. Wang, Y.X. and Y.H. Tan, 1987, Effects of berberine on action potentials in isolated myocardium and contraction in myocardium in vivo, J. Northwest. Pharmac. (China) 2, 11.
30. Wang, Y.X., X.J. Yao and Y.H. Tan, 1986, Antiarrnythmic action of berberine, Acta Fourth Mil. Med. Univ. (China) 7, 205.
31. Wang, Y.X., X.J. Yao and Y.H. Tan, 1987, Effects of berberine on physiologic properties of isolated guinea pig myocardium. Acta Pharmacol. Sin. 8, 220.
32. Wang, Y.X., G.Y. Zhao and Y.H. Tan, 1991, The negative chronotropic effect of berberine, J. Chin. Pharmacol. Toxicol. 5, 12.
33. Wang, Y.X., Y.H. Tan and B.H. Sheng, 1992a, Protective effect of berberine against cardiac arrhythmias following postischemic reperfusion and its mechanism, J. Chin. Circ. 7, 440.
34. Wang, Y.X., Y.H. Tan, B.H. Sheng and S.Y. Chen, 1992b, Characteristics of depressing effect of cycloprotobuxine-A on the maximal velocity of depolarization in myocardium, Eur. J. Pharmacol. 222, 219.
35. Wang, Y.X., Y.H. Tan and B.H. Sheng, 1993a. Effect of berberine on cardiac arrhythmia following coronary artery occlusion and its mechanism, J. Chin. Pharmacol. Toxicol. 7, 108.
36. Wang, Y.X., Y.H. Tan and B.H, Sheng, 1993b, Effects of berberine on ventricular fibrillation threshold and action potentials in rabbit myocardium in vivo, J. Chin. Pharmacol. Toxicol. 7, 34.
37. Wang, Y.X., X.J. Yao and Y.H. Tan, 1994, Effects of berberine on delayed aflerdepolarizations in ventricular muscles in vitro and in vivo, J. Cardiovasc. Pharmacol. 23, 716.
38. + loss in hypoxic and ischemic mammalian ventricle, J. Physiol. 447, 649.
39. Wolleben, C.D., M.C. Sanguinetti and P.K.S. Siegl, 1989, Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts, J. Mol. Cell. Cardiol. 21, 783.
40. Xu, Z., H.Y. Cao and Q. Li, 1989, Protective effects of berberine on spontaneous ventricular fibrillation in dogs after myocardial infarction, Acta Pharmacol. Sin. 10, 320.